Senores-new-logo-Oct-2023Senores-new-logo-Oct-2023Senores-new-logo-Oct-2023Senores-new-logo-Oct-2023
  • About Us
    • About Senores
    • Milestone
    • Leadership
    • Partnership
    • Corporate Film
  • Manufacturing
    • Formulations
    • API
  • Products
    • Formulation – Regulated Market
    • Formulation – Emerging Market
    • API
    • Critical Care – Hospital Line
    • Private Label
  • R&D
  • Investors
    • Offer Documents
    • Financials
    • Policies
    • Reports
    • Shareholding Pattern
    • Committees
    • Investor Contacts
    • Announcements
    • Corporate Governance Reports
    • Investor Meet
    • MOA-AOA
    • Reg. 46 of SEBI (LODR) Regulations
  • Contact

Policies
Code of Conduct for Directors and Senior Management Personnel
CSR Policy
Dividend Distribution Policy
Materiality Policy
Policy on Determination of Materiality of Events
Policy on Fair Disclosure on Unpublished Price Sensitive Information (UPSI)
Policy on Familiarization Program for Independent Directors
Policy on Material Subsidiaries
Policy on Preservation and Archival of Documents
Policy to Promote Diversity on the Board of Directors
Policy on Selection, Appointment, Performance Evaluation and Remuneration of Directors, Key Managerial Personnel and Senior Management
Policy on Succession Planning for the Board and Senior Management
Related Party Transactions Policy
Risk Management Policy
Web Archival Policy
Whistleblower Policy
Criteria for making payments to NEDs
Terms and Conditions for Appointment of Independent Director

Useful Links

  • About Us
  • Manufacturing
  • Products
  • Partnership
  • R&D
  • Regulatory
  • ADR
  • Media
  • Career
  • Contact

Disclaimer

• All the information present on Senores Pharmaceuticals website is not applicable to all the countries across the world. The  purpose  of   this  website is to provide information about Senores Pharmaceuticals' products and services. Any information present on the website shouldn't be misused or construed to spread or promote any of the products in the countries where are disapproved or prohibited.
• Listed  products  in this website will not be supplied to countries in which these could be in conflict with existing valid patents. The buyers should make their independent evaluation of the patent scenario for their respective market as the final responsibility lies exclusively with the buyer.
• Patented products will only be supplied for development, testing, and regulatory submission purposes.

© 2023 Senores Pharmaceuticals | All Rights Reserved.